News

Venus Remedies Ltd share price ticked higher by 4.22% to Rs 1455.25 after the company`s net profit rose by 11.67% to Rs 25.65 crore, while revenue from operations gained significantly 22.31% to Rs 218.76 crore in Q3FY26 over Q2FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.54 lakh crore, rising 3.38%. It has inched up 0.07% over last one week and edged lower by 3.01% in last one month while the market capitalization of Venus Remedies Ltd has eased by 8.59% and 9.54% in the same period respectively. Profit before tax (PBT) of Venus Remedies Ltd stood at Rs 33.47 crore in Q3 FY26, rallying 26.35% year-on-year, and climbing 11.42% quarter-on-quarter. EBITDA came in at Rs 42 crore, jumping 43.56% YoY and surging by 33.01% sequentially. Total expenses soared by 22.69% to Rs 185.8 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 97.39 crore, increasing 17.14% YoY, while employee benefits expense was at Rs 26.53 crore, surging 13.52% YoY. For the TTM ended FY26, revenue from operations improved 17.88% to Rs 769.6 crore, while net profit saw a strong growth of 126.81% to Rs 102.79 crore, compared to previous TTM. EBITDA jumped by 5474% to Rs 134.7 crore, and PBT jumped 86.80% to Rs 134.16 crore compared to previous TTM. The company`s consolidated net cash flow from operating activities stood at Rs 155.77 crore in FY26, as against Rs 86.45 crore in FY25. Venus Remedies Ltd surged by 232.86% in last one year, significantly outperforming the benchmark BSE Sensex which has declined by 13.18% during the same period.

Net profit of Venus Remedies rose 139.27% to Rs 22.97 crore in the quarter ended June 2026 as against Rs 9.60 crore during the previous quarter ended June 2025. Sales rose 30.38% to Rs 178.86 crore in the quarter ended June 2026 as against Rs 137.18 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales178.86137.18 30 OPM %19.1211.21 - PBDT36.8118.78 96 PBT30.0412.60 138 NP22.979.60 139 Powered by Capital Market - Live News

Venus Remedies will hold a meeting of the Board of Directors of the Company on 20 July 2026.

Venus Remedies announced that the 37th Annual General Meeting(AGM) of the company will be held on 20 August 2026.

Venus Remedies announced that the Board of Directors of the Company at its meeting held on 26 May 2026, inter alia, have recommended the final dividend of Rs 10 per equity Share (i.e. 100%) , subject to the approval of the shareholders.